SCHEMBL7829735

SCHEMBL7829735

NCCCNc1cccc2c1C(=O)c1c(N)ccc(N)c1C2=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NSD2 O96028 1/20 0.55
▸ FGB P02675 1/20 0.55
▸ MMP14 P50281 1/20 0.55
▸ MEN1 O00255 5/20 0.50
▸ KMT2A Q03164 5/20 0.50
▸ POLB P06746 4/20 0.50
▸ MAPT P10636 4/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ L3MBTL1 Q9Y468 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ EGFR P00533 2/20 0.50
▸ MAPK1 P28482 2/20 0.50
▸ HTT P42858 2/20 0.50
▸ BLM P54132 2/20 0.50
▸ LMNA P02545 1/20 0.50
▸ RAD52 P43351 1/20 0.50
▸ RECQL P46063 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ ADORA2A P29274 3/20 0.46
▸ CSNK1A1 P48729 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20334284 0.91 NSD2 (0.63) NSD2FGBMMP14MEN1KMT2A
SCHEMBL3853827 0.90 NSD2 (0.57) NSD2FGBMMP14MEN1KMT2A
SCHEMBL20333884 0.87 FGB (0.53) NSD2FGBMMP14MEN1KMT2A
SCHEMBL109325 0.87 MEN1 (0.64) NSD2FGBMMP14MEN1KMT2A
SCHEMBL6368226 0.86 NSD2 (0.61) NSD2FGBMMP14MEN1KMT2A
Hydrochloric Acid SCHEMBL6577424 0.85 MAPT (0.63) NSD2FGBMMP14MEN1KMT2A
SCHEMBL6372356 0.85 NSD2 (0.60) NSD2FGBMMP14MEN1KMT2A
SCHEMBL11648905 0.84 MEN1 (0.46) NSD2FGBMMP14MEN1KMT2A
SCHEMBL10581062 0.84 NSD2 (0.63) NSD2FGBMMP14MEN1KMT2A
SCHEMBL23787760 0.84 NSD2 (0.56) NSD2FGBMMP14MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4226784-A 2- and 5-Aminoalkylamino anthraquinone dyes useful as basic dyes in coloring hair L'OREAL (FR) 1980-10-07 — — US claimed
US-20230240954-A1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION L'OREAL (FR) 2023-08-03 — — US disclosed
US-20230240954-A1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION L'OREAL (FR) 2023-08-03 — — US disclosed
EP-3558235-B1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION OREAL (FR) 2021-09-08 — — EP disclosed
WO-2018115337-A1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION L'OREAL (FR) 2018-06-28 — — WO disclosed
EP-0758547-B1 Anthraquinone hair dyes having a quaternary ammonium side chain BRISTOL MYERS CO (US) 2001-08-16 — — EP disclosed
US-5891200-A Hair dye compositions containing anthraquinone dyes having a quaternary ammonium side chain and neutral direct dyes LIM MU-ILL (US) 1999-04-06 — — US disclosed
EP-0758547-A1 Anthraquinone hair dyes having a quaternary ammonium side chain Bristol-Myers Company (US) 1997-02-19 — — EP disclosed
US-5520707-A CATIONIC HAIR DYES CLAIROL, INC. (US) 1996-05-28 — — US disclosed
US-4226784-A 2- and 5-Aminoalkylamino anthraquinone dyes useful as basic dyes in coloring hair L'OREAL (FR) 1980-10-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240954-A1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION KRT18, CUTA, KLK5 NSD2 2000/4885FGB 247/4885MMP14 2125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback